胃肠支架市场规模、份额、成长分析、按产品、按材料、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球胃肠支架市场规模为4.432亿美元，从2023年的4.6713亿美元成长到2031年的7.1148亿美元，预计在预测期内（2024-2031年）将以复合年增长率增长。为5.4%）。

由于胃肠道疾病盛行率上升和人口老化，全球胃肠道支架市场正在强劲增长。由于生活方式的改变、不良的饮食习惯和肥胖率的上升，大肠直肠癌和发炎性肠道疾病肠道疾病等疾病呈上升趋势。因此，对胃肠支架的需求不断增加，因为它们提供了有效的微创治疗方法，可以改善患者的生活品质。老年人更容易受到与老龄化相关的胃肠道问题的影响，并且更喜欢支架等侵入性较小的选择，这一事实进一步推动了市场的发展。自膨胀金属支架 (SEMS) 和生物分解性支架等创新正在改善治疗效果和患者舒适度，并推动市场扩张。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

胃肠支架市场规模：依产品及复合年增长率（2024-2031）

• 市场概况
• 胆管支架
• 十二指肠支架
• 结肠支架
• 胰臟支架
• 食道支架

胃肠支架市场规模：依材料及复合年增长率（2024-2031）

• 市场概况
• 自膨式金属支架
• 镍钛诺
• 塑胶支架
• 其他的

胃肠支架市场规模：依应用与复合年增长率（2024-2031）

• 市场概况
• 胆道疾病
• 大肠激躁症
• 消化道癌症
• 大肠直肠癌
• 胃癌
• 食道癌
• 胰臟癌

胃肠支架市场规模：依最终用户及复合年增长率（2024-2031）

• 市场概况
• 医院和诊所
• 门诊手术中心

胃肠支架市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
• 产品系列分析
• 按细分市场分類的份额分析
• 收益与前一年同期比较（2021-2023）

主要企业简介

• 波士顿科学公司（美国）
• BD（贝克顿迪金森公司）（美国）
• 库克医疗（美国）
• 奥林巴斯公司（日本）
• Merit 医疗系统（美国）
• CONMED公司（美国）
• ELLA-CS sro（捷克共和国）
• 霍布斯医疗公司（美国）
• 泰熊医疗有限公司（韩国）
• S&G BIoTech Inc.（韩国）
• 美敦力（爱尔兰）
• 艾伯维（美国）
• 强生公司（美国）
• 武田药品工业株式会社（日本）
• 辉瑞公司（美国）
• 诺华公司（瑞士）
• 拜耳公司（德国）
• 阿斯特捷利康公司（英国）
• 罗氏控股公司（瑞士）
• 礼来公司（美国）

结论和建议

Global Gastrointestinal Stents Market size was valued at USD 443.2 million in 2022 and is poised to grow from USD 467.13 million in 2023 to USD 711.48 million by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

The global gastrointestinal stents market is witnessing robust growth, fueled by the escalating prevalence of gastrointestinal disorders and an aging population. Lifestyle changes, poor dietary habits, and rising obesity rates have led to an increase in conditions such as colorectal cancer and inflammatory bowel diseases. Consequently, the demand for gastrointestinal stents is on the rise, as they provide effective, less invasive treatment alternatives that enhance patient quality of life. The market is further bolstered by the elderly demographic, which is more susceptible to age-related gastrointestinal issues, fostering a preference for minimally invasive options like stents. Innovations such as self-expandable metal stents (SEMS) and biodegradable variants are transforming the landscape, offering improved outcomes and patient comfort, thereby driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gastrointestinal Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gastrointestinal Stents Market Segmental Analysis

Global Gastrointestinal Stents Market is segmented by products, material, application, end users and region. Based on products, the market is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents and esophageal stents. Based on material, the market is segmented into self-expanding metal stents, nitinol, plastic stents and others. Based on application, the market is segmented into biliary diseases, irritable bowel syndrome, gastrointestinal cancers, colorectal cancer, stomach cancer, esophageal cancer and pancreatic cancer. Based on end users, the market is segmented into hospitals and clinics and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gastrointestinal Stents Market

The Global Gastrointestinal Stents market is significantly driven by heightened awareness among patients and healthcare providers regarding the advantages of gastrointestinal stenting. This increased knowledge facilitates earlier diagnoses and timely medical interventions, which are crucial for effective treatment. Additionally, advancements in healthcare access, particularly in developing regions, have led to a rise in the adoption of stenting procedures. As more individuals gain access to quality healthcare services and understand the effectiveness of these stents, the overall demand in the market continues to grow, contributing to its ongoing expansion and evolution.

Restraints in the Global Gastrointestinal Stents Market

One significant restraint affecting the Global Gastrointestinal Stents market is the presence of limited reimbursement policies in certain regions. These policies can impose strict criteria on procedures involving gastrointestinal stents, which can significantly impact the affordability and accessibility of these treatments for patients. As a result, the financial burden on healthcare providers and patients can restrict the adoption of stent-based therapies, ultimately obstructing the overall growth and development of the market. Consequently, these reimbursement challenges may deter healthcare practitioners from recommending stent procedures, further limiting the potential market expansion.

Market Trends of the Global Gastrointestinal Stents Market

The global gastrointestinal stents market is witnessing a notable trend towards the adoption of biodegradable stents, driven by their clear advantages over traditional metallic alternatives. These innovative stents are designed to dissolve gradually, eliminating the need for invasive removal procedures, thus enhancing patient convenience and safety. As healthcare providers increasingly emphasize patient-centered care, the demand for biodegradable options is growing, reflecting a shift towards more effective and less invasive treatment methodologies. Additionally, biodegradable stents support the healing process by providing temporary structural integrity, making them a preferred choice for both clinicians and patients. This trend signifies a transformative phase within the gastrointestinal stent market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Gastrointestinal Stents Market Size by Products & CAGR (2024-2031)

• Market Overview
• Biliary Stents
• Duodenal Stents
• Colonic Stents
• Pancreatic Stents
• Esophageal Stents

Global Gastrointestinal Stents Market Size by Material & CAGR (2024-2031)

• Market Overview
• Self-Expanding Metal Stents
• Nitinol
• Plastic Stents
• Others

Global Gastrointestinal Stents Market Size by Application & CAGR (2024-2031)

• Market Overview
• Biliary Diseases
• Irritable Bowel Syndrome
• Gastrointestinal Cancers
• Colorectal Cancer
• Stomach Cancer
• Esophageal Cancer
• Pancreatic Cancer

Global Gastrointestinal Stents Market Size by End Users & CAGR (2024-2031)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgical Centers

Global Gastrointestinal Stents Market Size & CAGR (2024-2031)

• North America (Products, Material, Application, End Users)
  • USA
  • Canada
• Europe (Products, Material, Application, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Products, Material, Application, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Products, Material, Application, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Products, Material, Application, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONMED Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ELLA-CS s.r.o. (Czech Republic)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hobbs Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taewoong Medical Co. Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S&G Biotech Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations